X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18100) 18100
Magazine Article (41) 41
Book / eBook (15) 15
Book Chapter (12) 12
Publication (11) 11
Book Review (6) 6
Web Resource (6) 6
Dissertation (5) 5
Newsletter (2) 2
Reference (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16558) 16558
female (11312) 11312
male (11108) 11108
orthopedics (9976) 9976
aged (9917) 9917
middle aged (9481) 9481
arthroplasty, replacement, hip - adverse effects (7720) 7720
surgery (6385) 6385
adult (5140) 5140
arthroplasty (4902) 4902
treatment outcome (4893) 4893
aged, 80 and over (4754) 4754
replacement (4435) 4435
retrospective studies (3835) 3835
arthroplasty, replacement, knee - adverse effects (3720) 3720
prosthesis failure (3412) 3412
risk factors (2959) 2959
arthroplasty, replacement, hip - methods (2933) 2933
reoperation (2861) 2861
medicine & public health (2738) 2738
follow-up studies (2725) 2725
prosthesis design (2708) 2708
hip prosthesis - adverse effects (2634) 2634
total knee arthroplasty (2441) 2441
abridged index medicus (2271) 2271
hip (2239) 2239
hip prosthesis (2118) 2118
radiography (2117) 2117
joint surgery (2096) 2096
total hip-arthroplasty (2053) 2053
total hip arthroplasty (1988) 1988
time factors (1967) 1967
prospective studies (1961) 1961
analysis (1866) 1866
prosthesis (1863) 1863
arthroplasty, replacement, hip (1708) 1708
arthroplasty, replacement, hip - instrumentation (1704) 1704
osteoarthritis (1533) 1533
health aspects (1511) 1511
knee (1488) 1488
hip joint - surgery (1470) 1470
follow-up (1355) 1355
surgical orthopedics (1345) 1345
complications (1339) 1339
implants, artificial (1236) 1236
pain (1214) 1214
orthopedic surgery (1166) 1166
sports medicine (1163) 1163
arthroplasty, replacement, knee - methods (1156) 1156
osteoarthritis, hip - surgery (1155) 1155
outcomes (1148) 1148
conservative orthopedics (1092) 1092
postoperative complications - etiology (1076) 1076
young adult (1074) 1074
incidence (1063) 1063
total hip (1043) 1043
medicine/public health, general (1029) 1029
patients (1019) 1019
care and treatment (1018) 1018
knee arthroplasty (1012) 1012
management (971) 971
prostheses (963) 963
risk assessment (963) 963
risk (960) 960
revision (956) 956
recovery of function (941) 941
infection (936) 936
fractures (929) 929
mortality (899) 899
hip joint - diagnostic imaging (893) 893
adolescent (892) 892
postoperative complications - epidemiology (891) 891
prevention (889) 889
arthritis (879) 879
polyethylene (878) 878
range of motion, articular (875) 875
arthroplasty, replacement, knee (868) 868
cohort studies (854) 854
osteoarthritis, knee - surgery (854) 854
rheumatology (851) 851
postoperative complications (834) 834
knee joint - surgery (815) 815
hip joint (793) 793
acetabulum - surgery (790) 790
pain measurement (756) 756
femur - surgery (748) 748
risk-factors (744) 744
sport sciences (742) 742
femur (741) 741
wear (734) 734
medical research (730) 730
total joint arthroplasty (730) 730
medicine, general & internal (713) 713
anesthesiology (710) 710
prosthesis-related infections - etiology (707) 707
failure (695) 695
musculoskeletal diseases (691) 691
postoperative complications - prevention & control (688) 688
biomechanical phenomena (682) 682
dislocation (672) 672
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17451) 17451
German (254) 254
French (149) 149
Chinese (113) 113
Polish (67) 67
Spanish (63) 63
Czech (51) 51
Danish (35) 35
Japanese (31) 31
Russian (25) 25
Dutch (16) 16
Italian (13) 13
Swedish (11) 11
Norwegian (9) 9
Turkish (9) 9
Serbian (7) 7
Hungarian (5) 5
Portuguese (4) 4
Croatian (3) 3
Slovak (3) 3
Hebrew (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Finnish (1) 1
Korean (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous thromboembolism after hip replacement, without a significant increase in major bleeding... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85
...), for VTE prophylaxis after total knee arthroplasty (TKA) and total hip arthroplasty (THA), and discuss the appropriateness of combining the data... 
anticoagulants | thrombosis | prophylaxis | Embolism | Meta-analysis | Anticoagulants | Thrombosis | Prophylaxis | ENOXAPARIN | meta-analysis | RANDOMIZED-TRIAL | REPLACEMENT | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | THROMBOSIS PROPHYLAXIS | US HOSPITALS | PERIPHERAL VASCULAR DISEASE | THROMBOPROPHYLAXIS | HEMATOLOGY | UNFRACTIONATED HEPARIN | REGISTRY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Humans | Dabigatran | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Clinical Trials, Phase III as Topic | Enoxaparin - administration & dosage | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Risk Assessment | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Venous Thromboembolism - etiology | Hemorrhage - chemically induced | Administration | Phase III as Topic | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Pyridines/administration & dosage/adverse effects/therapeutic use | Arthroplasty | Replacement | Oral | Clinical Trials | Kirurgi | Knee/adverse effects | Hemorrhage/chemically induced | Venous Thromboembolism/etiology/mortality/prevention & control | Hip/adverse effects | Anticoagulants/administration & dosage/adverse effects/therapeutic use | Surgery | Enoxaparin/administration & dosage/adverse effects/therapeutic use
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2011, Volume 105, Issue 4, pp. 721 - 729
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus subcutaneous enoxaparin for extended thromboprophylaxis in patients undergoing total hip arthroplasty... 
Dabigatran etexilate | Oral anticoagulant | Total hip arthroplasty | Venous thromboembolism | Prophylaxis | SURGERY | DIRECT THROMBIN INHIBITOR | FONDAPARINUX | oral anticoagulant | PREVENTION | DEEP-VEIN THROMBOSIS | prophylaxis | total hip arthroplasty | KNEE REPLACEMENT | venous thromboembolism | MOLECULAR-WEIGHT HEPARIN | ETEXILATE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Dabigatran | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Benzimidazoles - administration & dosage | Hemorrhage - etiology | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Postoperative Complications | beta-Alanine - adverse effects | Double-Blind Method | Administration, Oral | Venous Thrombosis - mortality | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Venous Thromboembolism - etiology | Antithrombins - adverse effects | Survival Analysis | Arthroplasty, Replacement, Hip - mortality | Aged | Benzimidazoles | Venous Thrombosis | Oral | Hemorrhage | Antithrombins | Venous Thromboembolism | administration & dosage | Surgery | beta-Alanine | Administration | Anticoagulants | Subcutaneous | Enoxaparin | Arthroplasty | Replacement | prevention & control | Kirurgi | Hip | etiology | Injections | analogs & derivatives | adverse effects | mortality
Journal Article
Acta Orthopaedica, ISSN 1745-3682, 2009, Volume 77, Issue 2, pp. 177 - 197
Journal Article
Clinical orthopaedics and related research, ISSN 1528-1132, 2008, Volume 466, Issue 3, pp. 714 - 721
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article